Lymphoma |
Oncogenic |
BCL6‚ p19Arf
|
Cell transformation, cell growth |
38 |
Acute myeloid leukemia |
Oncogenic |
RUNX1/RUNX1T1 |
Proliferation |
39 |
Lung cancer |
Oncogenic |
miR-125a, miR-520e |
Cell cycle, cell growth, proliferation, apoptosis, invasion |
40-43, 69, 85 |
Oncosuppressive |
HP1γ, AXL, PVT1, ELK1 |
Proliferation, migration |
88 |
Hepatocellular carcinoma |
Oncogenic |
miR-125, miR-137, MEF2D, p53, p21,p27, cyclins, CDKs, PI3K/AKT, RAS/RAF/MEK/ERK, BCL2, FAS receptor, FADD, caspase-8, caspase-10 |
Cell cycle, proliferation, apoptosis, migration/metastasis, invasion |
37, 44-48, 65, 66 |
Oncosuppressive |
miR-106b |
Proliferation, apoptosis |
83 |
Prostate cancer |
Oncogenic |
STRN4, EGF |
Proliferation, apoptosis |
49, 50, 79 |
Oncosuppressive |
Sox9, AR |
Senescence, proliferation, invasion |
89, 92 |
Ovarian cancer |
Oncogenic |
MT1-MMP |
Migration/metastasis, invasion |
51 |
Breast cancer |
Oncogenic |
Survivin, SP1,Smad4 |
Proliferation, apoptosis |
52-55, 77 |
Gastric cancer |
Oncogenic |
C/EBPα/ miR-100 |
Proliferation, migration/metastasis |
55 |
Oncosuppressive |
Not defined |
Cell cycle, apoptosis, migration/metastasis |
95 |
Glioma |
Oncogenic |
AKT, cyclins, CDKs, NF-κB, Survivin |
Cell cycle, proliferation, apoptosis, migration/metastasis |
56 |
Sarcoma/mesenchymal tumors |
Oncogenic |
p21, p53, miR-663a, LncRNA GAS5, circular RNA of LRF/ZBTB7A - ILF2/3 |
Cell cycle, proliferation, apoptosis, migration/metastasis, invasion, angiogenesis |
57, 58, 68, 103 |
Oncosuppressive |
DLK1, Sox9 |
Cell transformation, proliferation |
93, 103 |
Colorectal cancer |
Oncogenic |
DAP5/p53, ETS-1 |
Cell cycle, proliferation, apoptosis, migration/metastasis, invasion |
59-62 |
Renal carcinoma |
Oncogenic |
miR-137 |
Proliferation, invasion |
63 |
Liver cancer |
Oncogenic |
miR-21, Sprouty1 |
Cell growth, proliferation |
84 |
Bladder cancer |
Oncogenic |
TGF-β |
Cell growth, migration/metastasis, invasion |
81 |
Melanoma |
Oncosuppressive |
MCAM |
Migration/metastasis |
96 |